These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34098976)

  • 1. Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series.
    Brown RA; Barbar-Smiley F; Yildirim-Toruner C; Ardura MI; Ardoin SP; Akoghlanian S
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):84. PubMed ID: 34098976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Kotb A; Christensen R; Mudano AS; Maxwell LJ; Shah NP; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012183. PubMed ID: 27175934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies.
    Mok CC; Ho LY; Tse SM; Chan KL; To CH
    Clin Rheumatol; 2023 Apr; 42(4):1019-1026. PubMed ID: 36385600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Uziel Y; Moshe V; Onozo B; Kulcsár A; Tróbert-Sipos D; Akikusa JD; Salviato Pileggi G; Maritsi D; Kasapcopur O; Rodrigues M; Smerla R; Rigante D; Makay B; Atsali E; Wulffraat N; Toplak N;
    Vaccine; 2020 Feb; 38(9):2198-2201. PubMed ID: 31987692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
    Chiu YM; Chen DY
    Expert Rev Clin Immunol; 2020 Feb; 16(2):207-228. PubMed ID: 31852268
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
    McMahan R; Balfe LM; Greene L
    J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing trend in the incidence of serious pneumonias in Finnish children with juvenile idiopathic arthritis.
    Salonen PH; Salonen JH; Säilä H; Helminen M; Linna M; Kauppi MJ
    Clin Rheumatol; 2020 Mar; 39(3):853-860. PubMed ID: 31732822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.
    Peinado-Acevedo JS; Varela DC; Hidrón A
    Rheumatol Int; 2021 Sep; 41(9):1673-1680. PubMed ID: 33150492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy.
    Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Tsitsami E; Kyriazopoulou-Dalaina V
    Clin Exp Rheumatol; 2001; 19(5):589-94. PubMed ID: 11579723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Soliman MM; Ashcroft DM; Watson KD; Lunt M; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2011 Apr; 70(4):583-9. PubMed ID: 21330639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide treatment in juvenile idiopathic arthritis.
    Ayaz NA; Karadağ ŞG; Çakmak F; Çakan M; Tanatar A; Sönmez HE
    Rheumatol Int; 2019 Sep; 39(9):1615-1619. PubMed ID: 31327053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
    Furia FF; Godfrey E; Mwamanenge N; Swai P
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.
    Hazlewood GS; Barnabe C; Tomlinson G; Marshall D; Devoe DJ; Bombardier C
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010227. PubMed ID: 27571502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of paediatric rheumatic diseases in Nigeria.
    Olaosebikan BH; Adelowo OO; Animashaun BA; Akintayo RO
    Pediatr Rheumatol Online J; 2017 Jan; 15(1):7. PubMed ID: 28143550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.